Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Embryonic Stem Cells/Induced Pluripotent Stem (iPS) Cells"'
Autor:
Koji Eto, Tatsutoshi Nakahata, Shoichi Hirose, Hiromitsu Nakauchi, Naoya Takayama, Kiyosumi Ochi
Publikováno v:
Stem Cells Translational Medicine. 3:792-800
Adult hemoglobin composed of α- and β-globin reflects a change from expression of embryonic ε- and fetal γ-globin to adult β-globin in human erythroid cells, so-called globin switching. Human pluripotent stem cells (hPSCs) are a potential source
Autor:
Mi Yoon Chang, Sanghyeok Ko, Paulo Sng Man Yoo, Jeong Tae Do, Robert Lanza, Chengsheng Zhang, Kwang Soo Kim, Rebecca C. Iskow, Dohoon Kim, Min-Joon Han, Chun-Hyung Kim, Hansoo Park, Eun Gyo Lee, Ryan E. Mills, Hyun Woo Choi, Jung Il Moon, Joon Ki Jung
Publikováno v:
Stem Cells Translational Medicine. 3:599-609
It has recently been shown that genomic integrity (with respect to copy number variants [CNVs]) is compromised in human induced pluripotent stem cells (iPSCs) generated by viral-based ectopic expression of specific transcription factors (e.g., Oct4,
Publikováno v:
Riazifar, H; Jia, Y; Chen, J; Lynch, G; & Huang, T. (2014). Chemically induced specification of retinal ganglion cells from human embryonic and induced pluripotent stem cells. Stem Cells Translational Medicine, 3(4), 424-432. doi: 10.5966/sctm.2013-0147. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/88f2s80h
The loss of retinal ganglion cells (RGCs) is the primary pathological change for many retinal degenerative diseases. Although there is currently no effective treatment for this group of diseases, cell transplantation to replace lost RGCs holds great
Autor:
Kevin Lai, Thuy Ai Huyen Le, Monica Bennett, Bahram Valamehr, Peter Flynn, David J. Robbins, Tom Tong Lee, Ramzey Abujarour, Megan Robinson
Publikováno v:
Stem Cells Translational Medicine. 3:149-160
Human induced pluripotent stem cells (iPSCs) represent a scalable source of potentially any cell type for disease modeling and therapeutic screening. We have a particular interest in modeling skeletal muscle from various genetic backgrounds; however,
Autor:
Noushin Dianat, Inmaculada Moreno-Gimeno, Eléanor Luce, Anne Dubart-Kupperschmitt, Gérard Tachdjian, Joëlle Marie, Clara Steichen, Lucie Tosca, Jérome Maluenda, Deborah J. Burks, Christophe Desterke, Judith Melki, Sylvie Goulinet-Mainot, Sarah Awan-Toor, Anne Weber
Publikováno v:
Stem Cells Translational Medicine
r-CIPF: Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Centro de Investigación Principe Felipe (CIPF)
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
instname
r-CIPF: Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Centro de Investigación Principe Felipe (CIPF)
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
instname
The use of synthetic messenger RNAs to generate human induced pluripotent stem cells (iPSCs) is particularly appealing for potential regenerative medicine applications, because it overcomes the common drawbacks of DNA-based or virus-based reprogrammi
Autor:
Susana Villate, Camillo Ricordi, R. D. Molano, Christopher A. Fraker, Antonello Pileggi, Silvia Álvarez-Cubela, Luca Inverardi, Sirlene Cechin, Jaime A. Giraldo, Juan Domínguez-Bendala
Publikováno v:
Stem Cells Translational Medicine. 3:277-289
The possibility of using human embryonic stem (hES) cell-derived β cells as an alternative to cadaveric islets for the treatment of type 1 diabetes is now widely acknowledged. However, current differentiation methods consistently fail to generate me
Autor:
Chi-Wing Kong, Deborah K. Lieu, Roger J. Hajjar, Francesca Stillitano, Grant Senyei, Lihuan Ren, Ioannis Karakikes, Evren U. Azeloglu, Ravi Iyengar, Jiaxian Wang, Jens Hansen, Jean-Sébastien Hulot, Ronald A. Li
Publikováno v:
Stem Cells Translational Medicine. 3:18-31
The generation of human ventricular cardiomyocytes from human embryonic stem cells and/or induced pluripotent stem cells could fulfill the demand for therapeutic applications and in vitro pharmacological research; however, the production of a homogen
Autor:
Brendan A.S. McIntyre, Borhane Guezguez, Rami Mechael, Mickie Bhatia, Aline Fiebig-Comyn, Yuping Wu, Kyle R. Salci, Jung Bok Lee, Guojun Sheng, Cantas Alev
Publikováno v:
Stem Cells Translational Medicine. 3:7-17
Production of human embryonic stem cell (hESC)-derived lung progenitors has broad applicability for drug screening and cell therapy; however, this is complicated by limitations in demarcating phenotypic changes with functional validation of airway ce
Autor:
Rui-Zhe Phang, Wee Kiat Tan, Han Chong Toh, Johan Chin-Kang Tay, Felix Chang Tay, Zhendong Li, Sal-Lee Goh, Cia-Hin Lau, Haibao Zhu, Can Chen, Shouhui Du, Weimin Fan, Chunxiao Wu, Shu Wang, Jieming Zeng, Qingle Liang
Publikováno v:
Stem Cells Translational Medicine. 2:935-945
Integrative gene transfer using retroviruses to express reprogramming factors displays high efficiency in generating induced pluripotent stem cells (iPSCs), but the value of the method is limited because of the concern over mutagenesis associated wit
Publikováno v:
Stem Cells Translational Medicine. 2:929-934
Glut2 is one of the facilitative glucose transporters expressed by preimplantation and early postimplantation embryos. Glut2 is important for survival before embryonic day 10.5. The Glut2 KM (∼16 mmol/liter) is significantly higher than physiologic